CorMedix Inc — Quarterly Cash Flow (NASDAQ:CRMD) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Total assets 77.59 M118.85 M149.58 M252.6 M750.86 M Total liabilities 18.87 M34.19 M34.69 M31.97 M376.73 M Total equity 58.71 M84.66 M114.89 M220.63 M374.13 M Total liabilities & shareholders' equities 77.59 M118.85 M149.58 M252.6 M750.86 M Total debt ————— Net debt —————

Новости

Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates

CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet?

Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings?

CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock?

CorMedix Inc. (CRMD) Analyst/Investor Day Transcript

CorMedix Inc. (CRMD) Analyst/Investor Day - Slideshow (NASDAQ:CRMD) 2026-02-11

Citizens подтверждает рейтинг Market Outperform для акций CorMedix

CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside

Акции CorMedix растут после объявления о выкупе акций на $75 млн

CorMedix stock rises after announcing $75 million share buyback plan

CorMedix объявляет о программе обратного выкупа акций на $75 млн

CorMedix announces $75 million share repurchase program